Humacyte to Present at the Piper Sandler 35th Annual Healthcare Conference

December 15, 2023

https://www.globenewswire.com/news-release/2023/11/24/2785569/0/en/Humacyte-to-Present-at-the-Piper-Sandler-35th-Annual-Healthcare-Conference.html

DURHAM, N.C., Nov. 24, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq:HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced that Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, and Dale Sander, Chief Financial Officer, will present at the Piper Sandler 35th Annual Healthcare Conference, in New York, NY on November 30, 2023. Management will also be available for one-on-one meetings.

Read more at globenewswire.com

Related news for (HUMA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.